Catalyst Wire Dossier Catalyst Wire Dossier

Pegolsihematide

· Jiangsu Hansoh Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Pegolsihematide, covering 2015-10-26 to 2015-12-02. Get the full timeline:

Most recent: Clinical Trial Update: Safety & Pharmacokinetics of Pegolsihematide for Treatment of Anemia Patient With Myelodysplastic Syndromes [Phase 1]

See pricing